Head and neck cancers mortality statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Deaths

Deaths from head and neck cancer, 2015-2017, UK.

 

Percentage of all deaths

Percentage head and neck cancer contributes to total cancer deaths, 2015-2017, UK

 

Age

Peak mortality rate for head and neck cancer, 2015-2017, UK

Trend over time

Change in head and neck cancer mortality rates since the early 1970s, UK

Head and neck cancer is the 15th most common cause of cancer death in the UK, accounting for 2% of all cancer deaths (2017).[1-3]

In females in the UK, head and neck cancer is the 17th most common cause of cancer death (2% of all female cancer deaths). In males in the UK it is the 10th most common cause of cancer death (3% of all male cancer deaths).

29% of head and neck cancer deaths in the UK are in females, and 71% are in males.

Head and neck cancer mortality rates (European age-standardised (AS) rates) Open a glossary item for persons are significantly higher than the UK average in Scotland, significantly lower than the UK average in England, and similar to the UK average in all other UK constituent countries.

Head and Neck Cancer (C00-C14, C30-C32), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2017

  England Scotland Wales Northern Ireland UK
Female Deaths 910 144 69 50 1,173
Crude Rate 3.2 5.2 4.4 5.3 3.5
AS Rate 3.2 5.0 3.9 5.8 3.5
AS Rate - 95% LCL 3.0 4.2 3.0 4.2 3.3
AS Rate - 95% UCL 3.4 5.8 4.9 7.4 3.7
Male Deaths 2,296 377 177 79 2,929
Crude Rate 8.4 14.3 11.5 8.6 9.0
AS Rate 9.6 15.9 11.8 10.5 10.3
AS Rate - 95% LCL 9.2 14.3 10.1 8.2 9.9
AS Rate - 95% UCL 10.0 17.5 13.6 12.8 10.7
Persons Deaths 3,206 521 246 129 4,102
Crude Rate 5.8 9.6 7.9 6.9 6.2
AS Rate 6.2 9.9 7.6 8.0 6.6
AS Rate - 95% LCL 6.0 9.1 6.7 6.6 6.4
AS Rate - 95% UCL 6.4 10.8 8.6 9.4 6.8

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item

For head and neck cancer, there are mortality differences between countries despite there being no such differences in incidence.

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C00-C14, C30-C32.

Last reviewed:

Head and neck cancer mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2015-2017, on average each year more than a third (36%) of deaths were in people aged 75 and over.[1-3] This is a lower proportion of deaths in older age groups compared with most cancers.

Age-specific mortality rates rise steadily from around age 40-45 and more steeply from around age 80-84. The highest rates are in the 90+ age group for females and males. Mortality rates are significantly lower in females than males in a number of (mainly older) age groups. The gap is widest at age 70 to 74,when the age-specific mortality rate is 3.3 times lower in females than in males.

Head And Neck Cancer (C00-C14, C30-C32), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Population, UK, 2015-2017

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, ICD-10 C00-C14, C30-C32.

Last reviewed:

Head and neck cancer European age-standardised (AS) Open a glossary item mortality rates for females and males combined decreased by 9% in the UK between 1971-1973 and 2015-2017.[1-3] The decrease was of a similar size in females and males.

For females, head and neck cancer AS mortality rates in the UK decreased by 14% between 1971-1973 and 2015-2017. For males, head and neck cancer AS mortality rates in the UK decreased by 21% between 1971-1973 and 2015-2017.

Over the last decade in the UK (between 2005-2007 and 2015-2017), head and neck cancer AS mortality rates for females and males combined increased by 16%.[1-3] In females AS mortality rates increased by 15%, and in males rates increased by 14%.

Head And Neck Cancer (C00-C14, C30-C32), European Age-Standardised Mortality Rates per 100,000 Population, UK, 1971-2017

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Head and neck cancer mortality rates have decreased overall in some broad adult age groups in females in the UK since the early 1970s, but have remained stable in others.[1-3] Rates in 25-49s have decreased by 40%, in 50-59s have decreased by 19%, in 60-69s have remained stable, in 70-79s have remained stable, and in 80+s have decreased by 15%.

Head And Neck Cancer (C00-C14, C30-C32), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Females, UK, 1971-2017

Head and neck cancer mortality rates have varied between age groups in males in the UK since the early 1970s.[1-3] Rates in 25-49s have remained stable, in 50-59s have increased by 16%, in 60-69s have increased by 13%, in 70-79s have decreased by 31%, and in 80+s have decreased by 43%.

Head And Neck Cancer (C00-C14, C30-C32), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Males, UK, 1971-2017

References

  1. Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2017, C00-C14, C30-C32.

Last reviewed:

Overall there is evidence for an association between oral cavity cancer mortality and deprivation for both males and females in England, however, there is no association between laryngeal cancer mortality and deprivation for females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 218-298% higher for males living in the most deprived areas compared with the least deprived, and 59-257% higher for females.[1]

Head and Neck Cancer Subtypes, European Age-Standardised Mortality Rates by Deprivation Quintile, Males England, 2007-2011

Head and Neck Cancer Subtypes, European Age-Standardised Mortality Rates by Deprivation Quintile, Females England, 2007-2011

The estimated deprivation gradient in head and neck cancer mortality for males and females living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It has been estimated that there would have been around 190-260 fewer cancer deaths each year in England during 2007-2011 if all people experienced the same mortality rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for England, 2006-2010, Head and Neck cancer, ICD-10 codes (C01 and C09-C10, C02-C04 and C32)

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.